Study of the switching from fingolimod to dimethyl fumarate in multiple sclerosis patients

Takamichi Sugimoto

Presentation information

Japanese Poster Session

[Pj-021] Neuroimmunology (MS and disease modifying therapy1)

Wed. May 22, 2019 5:20 PM - 6:35 PM Poster Exhibition (Osaka International Convention Center 3F Event Hall)

Chair:Chiyoko Nohara(Tokyo Metropolitan Health and Medical Treatment Corporation Ebara Hospital)

[Pj-021-5] Study of the switching from fingolimod to dimethyl fumarate in multiple sclerosis patients

Takamichi Sugimoto¹, Roi Ishikawa¹, Taku Tazuma¹, Masahiro Hayashi¹, Naoko Mine¹, Haruka Ishibashi¹, Kazuhide Ochi², Eiichi Nomura¹, Tatsuo Kohriyama³, Takemori Yamawaki¹ (1.Department of Neurology, Hiroshima City Hiroshima Citizens Hospital, 2.Department of Neurology, Hiroshima City Asa Citizens Hospital, 3.Department of Neurology, Brain Attack Center, Ota Memorial Hospital)

Abstract password authentication.
Password is written on a pocket program and name badge.